Purchase On Demand Above (Recommended)
Purchase on USB
Find a Live CME Meeting in Your Medical Specialty
CME Expiration Date 1/31/2026
|
Multiparametric Prostate MRI
Neil M. Rofsky, M.D., FACR
|
0.50 Hrs |
$45.00 |
Add to Cart |
|
PET/CT in Prostate Cancer (PSMA imaging) and Theranostics
Terence Z. Wong, M.D., Ph.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
MRI of Prostate Cancer
Russell N. Low, M.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
PSMA Scanning: What You Need to Know
Neil M. Rofsky, M.D., FACR
|
0.50 Hrs |
$45.00 |
Add to Cart |
|
Ra-223 Dichloride & Lu-177 PSMA-617 TNM for Metastatic Prostate Cancer Management: Challenging Cases
Erik S. Mittra, M.D., Ph.D.
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
PIRADS: Knowns and Unknowns
Neil M. Rofsky, M.D., FACR
|
0.75 Hrs |
$67.50 |
Add to Cart |
|
What's New in Prostate Pathology?
Sean R. Williamson, M.D.
|
1.00 Hrs |
$90.00 |
Add to Cart |
|
Prostate Cancer 2022
Cristina Magi-Galluzzi, M.D., Ph.D.
|
1.00 Hrs |
$90.00 |
Add to Cart |
|
Intraductal Lesions of the Prostate
Jonathan I. Epstein, M.D.
|
1.00 Hrs |
$90.00 |
Add to Cart |
|
False Positive, False Negative and Atypical: (Uncertain) Diagnoses in Prostate Pathology - Important Traps to Avoid
Kiril Trpkov, M.D., FRCPC
|
1.00 Hrs |
$90.00 |
Add to Cart |
This CME teaching activity is designed to provide a clinical perspective of the diagnosis, imaging and management of prostate disorders including a review of the American College of Radiology Prostate Imaging Reporting & Data System (PI-RADS) lexicon updates. This series highlights current imaging, pathologic diagnosis and treatment options for prostate cancer and the impact on patient care overall. The imaging review is followed by a pathology correlation which includes multiple case presentations, diagnostic challenges and advances in grading and reporting prostate cancer.
This program is designed to educate physicians who diagnose and treat prostate disease: Radiologists, Urologists and Radiation Oncologists, Medical Oncologists, Pathologists and any other physicians that diagnose and treat prostate cancer.
Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Educational Symposia designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All activity participants are required to complete the credit application in order to be awarded credit. Course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.
AMA PRA Category 1 Credit(s)TM for these programs may be claimed until January 31, 2026.
This program is planned and organized by Educational Symposia, a leader in accredited continuing education since 1975.
This activity was planned and produced in accordance with the ACCME Essential Areas and Elements.
At the completion of this CME teaching activity, you should be able to:
-
Discuss the clinical indications and applications of performing prostate MRI.
-
Discuss the utility of multi-parametric diagnostic MRI for the detection and localization of prostate cancer.
-
Describe the utility of PET/CT in prostate cancer evaluation.
-
Describe the optimal approach to diagnostic imaging of recurrent and metastatic prostate cancer.
-
Compare the use of theranostics with other forms of prostate cancer management therapies.
-
Increase knowledge of the PI-RADS lexicon.
-
Discuss the recent advances in the reporting of prostatic adenocarcinoma.
-
Recognize mimickers of prostate cancer.
-
Review intraductal lesions of the prostate.
-
Recognize the most important diagnostic challenges in assessing prostate needle biopsies.
-
Describe diagnostic challenges associated with prostate needle biopsy specimens.
No special educational preparation is required for this CME activity.
Professor, Departments of Pathology, Urology & Oncology
The Reinhard Professor of Urologic Pathology
Johns Hopkins Medical Institutions
Director of Surgical Pathology
Director of Anatomic Pathology Consult Service
Department of Pathology, Johns Hopkins Hospital Baltimore, MD
Baltimore, MD
Medical Director
Sharp and Children's MRI Center
San Diego, CA
Professor of Pathology
Director, Division of Anatomic Pathology
The C. Bruce Alexander Endowed Professorship in Pathology
Section Head, Genitourinary Pathology
Director, Genitourinary Pathology Fellowship Program
The University of Alabama at Birmingham
Birmingham, AL
Professor, Diagnostic Radiology
Chief, Molecular Imaging and Therapy
Oregon Health & Science University
Portland, OR
Professor and Chairman
Effie and Wofford Cain Distinguished Chair in Diagnostic Imaging
Department of Radiology
UT Southwestern Medical Center
Dallas, TX
Professor of Pathology
Genitourinary Pathology Group Leader
Department of Pathology and Laboratory Medicine
University of Calgary and Alberta Precision Labs
Calgary, AB
CANADA
Staff Pathologist
Cleveland Clinic
Cleveland, OH
Chief, Nuclear Medicine and Radiotheranostics
Professor of Radiology
Professor in Medicine, Medical Oncology
Duke University Medical Center
Duke Cancer Institute
Durham, NC